Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
出版年份 2015 全文链接
标题
Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 2, Pages e0118195
出版商
Public Library of Science (PLoS)
发表日期
2015-02-13
DOI
10.1371/journal.pone.0118195
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy
- (2013) William N. William et al. Journal of Thoracic Oncology
- Management of non-small-cell lung cancer: recent developments
- (2013) Martin Reck et al. LANCET
- DNA methylation: roles in mammalian development
- (2013) Zachary D. Smith et al. NATURE REVIEWS GENETICS
- Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
- (2013) Dimo Dietrich et al. PLoS One
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- The role of DNA methylation as biomarkers in the clinical management of lung cancer
- (2013) Michael Fleischhacker et al. Expert Review of Respiratory Medicine
- Non-Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers
- (2013) Ronald Scheff et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer
- (2012) Shibu Varughese et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
- (2012) J.-C. Soria et al. ANNALS OF ONCOLOGY
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients
- (2012) Dimo Dietrich et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Circulating Tumor Cells and Circulating Tumor DNA
- (2011) Catherine Alix-Panabières et al. Annual Review of Medicine
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Epigenetics and gene expression
- (2010) E R Gibney et al. HEREDITY
- Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
- (2010) N. Thatcher et al. ONCOLOGIST
- Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
- (2008) S. Holdenrieder et al. CLINICAL CANCER RESEARCH
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
- (2008) Stefan Holdenrieder et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started